Blood test could revolutionize kidney cancer detection
NCT ID NCT06917560
Summary
This research aims to develop a blood test that detects specific antibodies to help diagnose kidney cancer earlier and predict which patients might benefit most from immunotherapy. Researchers are analyzing medical records and blood samples from 400 patients who already had kidney cancer treatment. The goal is to create a tool that helps doctors make more personalized treatment decisions and improve patient outcomes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
first hospital affiliated of Fujian medical university
Fuzhou, Fujian, 350005, China
Conditions
Explore the condition pages connected to this study.